| scholarly article | Q13442814 |
| P2093 | author name string | Rubinstein E | |
| Athamna A | |||
| Athamna M | |||
| Medlej B | |||
| Bast DJ | |||
| Abu-Rashed N | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Bacillus anthracis | Q614156 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 424-428 | |
| P577 | publication date | 2004-06-17 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Selection of Bacillus anthracis isolates resistant to antibiotics | |
| P478 | volume | 54 |
| Q89977362 | A Survey of Antimicrobial Resistance Determinants in Category A Select Agents, Exempt Strains, and Near-Neighbor Species |
| Q33962839 | A rapid antimicrobial susceptibility test for Bacillus anthracis |
| Q28075453 | Alternative pre-approved and novel therapies for the treatment of anthrax |
| Q41702872 | An antimicrobial guanidine-bearing sesterterpene from the cultured cyanobacterium Scytonema sp. |
| Q48568241 | Anthrax attacks: lessons learned on the 10th anniversary of the anthrax attacks |
| Q37262118 | Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax |
| Q35610439 | Antibodies against anthrax: mechanisms of action and clinical applications |
| Q42589414 | Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua |
| Q47160212 | Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): anthrax |
| Q34101821 | Channel-forming bacterial toxins in biosensing and macromolecule delivery |
| Q34514999 | Characteristics of a broad lytic spectrum endolysin from phage BtCS33 of Bacillus thuringiensis |
| Q29391211 | Characterization and comparative genomic analysis of bacteriophages infecting members of the Bacillus cereus group |
| Q47751165 | Complete Genome Sequences of Three Bacillus anthracis Bacteriophages. |
| Q28386084 | Conference report on public health and clinical guidelines for anthrax |
| Q36295305 | Daptomycin exerts rapid bactericidal activity against Bacillus anthracis without disrupting membrane integrity |
| Q27651378 | Design and Synthesis of Aryl Ether Inhibitors of theBacillus AnthracisEnoyl-ACP Reductase |
| Q47558565 | Disaster Preparedness: Biological Threats and Treatment Options |
| Q90009925 | Establishment of a New Zealand White Rabbit Model for Lethal Toxin (LT) Challenge and Efficacy of Monoclonal Antibody 5E11 in the LT-Challenged Rabbit Model |
| Q35759041 | Evaluation of the metS and murB loci for antibiotic discovery using targeted antisense RNA expression analysis in Bacillus anthracis. |
| Q26746975 | Flavin-Dependent Thymidylate Synthase as a New Antibiotic Target |
| Q41973066 | Functional comparison of the two Bacillus anthracis glutamate racemases |
| Q39641367 | Hapalindole-related alkaloids from the cultured cyanobacterium Fischerella ambigua |
| Q33285349 | High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation |
| Q35806278 | Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model |
| Q34700759 | Investigation of antimicrobial and protease-inhibitory activity from cultured cyanobacteria |
| Q28383505 | Is in vitro antibiotic combination more effective than single-drug therapy against anthrax? |
| Q27652732 | Kinetic and X-Ray Structural Evidence for Negative Cooperativity in Substrate Binding to Nicotinate Mononucleotide Adenylyltransferase (NMAT) from Bacillus anthracis |
| Q58704184 | Loss of Bacitracin Resistance Due to a Large Genomic Deletion among Strains |
| Q48860210 | Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers |
| Q35227109 | Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin. |
| Q35097748 | Microevolution during an Anthrax outbreak leading to clonal heterogeneity and penicillin resistance |
| Q30570720 | Molecular motions as a drug target: mechanistic simulations of anthrax toxin edema factor function led to the discovery of novel allosteric inhibitors |
| Q28393072 | Monoclonal antibody therapies against anthrax |
| Q34066161 | New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis |
| Q34108521 | Oligochlorophens are potent inhibitors of Bacillus anthracis |
| Q29248800 | Optical Screening for Rapid Antimicrobial Susceptibility Testing and for Observation of Phenotypic Diversity among Strains of the Genetically Clonal Species Bacillus anthracis |
| Q34194728 | Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region |
| Q36565152 | Past, imminent and future human medical countermeasures for anthrax |
| Q41892311 | PlyPH, a bacteriolytic enzyme with a broad pH range of activity and lytic action against Bacillus anthracis |
| Q34176948 | Possible use of bacteriophages active against Bacillus anthracis and other B. cereus group members in the face of a bioterrorism threat. |
| Q36901955 | Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism |
| Q34368520 | Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis |
| Q33682212 | Rapid identification of genetic modifications in Bacillus anthracis using whole genome draft sequences generated by 454 pyrosequencing |
| Q55361721 | Single vector platform vaccine protects against lethal respiratory challenge with Tier 1 select agents of anthrax, plague, and tularemia. |
| Q24643595 | Structural and functional analysis of two glutamate racemase isozymes from Bacillus anthracis and implications for inhibitor design |
| Q34219646 | Structure determination and interception of biosynthetic intermediates for the plantazolicin class of highly discriminating antibiotics. |
| Q46242316 | Synthesis of α-branched acyclic nucleoside phosphonates as potential inhibitors of bacterial adenylate cyclases |
| Q92235377 | The PlyB Endolysin of Bacteriophage vB_BanS_Bcp1 Exhibits Broad-Spectrum Bactericidal Activity against Bacillus cereus Sensu Lato Isolates |
| Q52587550 | The bioterrorism threat and dual-use biotechnological research: an Israeli perspective. |
| Q35888254 | The efficacy and safety of nine South African medicinal plants in controlling Bacillus anthracis Sterne vaccine strain |
| Q40103244 | The fluorocycline TP-271 is efficacious in models of aerosolized Bacillus anthracis infection in BALB/c mice and cynomolgus macaques |
| Q39638623 | The future of biological warfare |
Search more.